Zvonko Milicevic

Head of Department for Science, Education, Projects and Clinical Research at Clinical Hospital "Sveti Duh"

Austria

About

Experience

  • Head of Department for Science, Education, Projects and Clinical Research at Klinička bolnica "Sveti Duh"
    Jan 2025 - Present · 1 yr 6 mos

  • Eli Lilly and Company (Full-time · 27 yrs)
    • Vice President – Next Generation Incretins
      Jan 2023 - Dec 2024 · 2 yrs

      • Program leader for the development of retatrutide. • Clinical program leader for the research of the mechanism of action of retatrutide.

    • Vice President – Next Generation Incretins
      Jan 2017 - Dec 2022 · 6 yrs

      • Program leader for dual and triple-action oral and injectable incretin receptor agonists. • Clinical program leader for the mechanism of action research program for the dual receptor agonist tirzepatide. • Clinical leader for the early development of retatrutide, a triple-action incretin receptor agonist. • Overall strategy for programs related to dual and triple incretin receptor agonists tirzepatide and retatrutide, as well as the oral GLP-1 receptor agonist orforglipron.

    • Clinical Research Physician
      Jan 2008 - Dec 2016 · 9 yrs

      • Key responsibilities: global medical and regulatory strategy for drug approval, strategy leader for drug approval in the EU. • Responsible for the design and implementation of registration clinical trials. • Strategy for collaboration with key experts and implementation of the plan.

  • Physician at Institute of Diabetes, Endocrinology and Metabolic Diseases
    Jan 1984 - Dec 1997 · 14 yrs

    • Head of the Metabolic Diseases Department. • Head of the Department for Clamp Procedure Applications in Metabolic Research.